ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will present today at the Oppenheimer & Co. 26th Annual Healthcare Conference at the Westin Grand Central Hotel in New York City. Arthur S. Przybyl,...

Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today announced positive data for VYXEOS™ (also known as CPX-351) were presented in two presentations at the 57th American Society of Hematology...

ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, reports positive results regarding...

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT), a leading independent producer of specialty hydrocarbon and fuels products, today announced that management will attend the following...

Results from a sub-analysis of the Phase 2 RESONATE-17 (PCYC-1117) study showed IMBRUVICA® (ibrutinib) was associated with robust efficacy and a positive risk-benefit profile in patients with...